Stay updated on Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Sign up to get notified when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.

Latest updates to the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry, v3.5.3, was added to the Record History, replacing the previous v3.5.2 as the latest version.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision history now includes a new entry for v3.5.2. The previous v3.5.0 entry has been removed.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision history now includes a new entry for v3.5.0 and removes the previous v3.4.3 entry.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision v3.4.3 appears in the history, replacing the previous v3.4.2.SummaryDifference0.1%

- Check89 days agoChange DetectedThe Study Record History now includes a new revision entry v3.4.2, replacing the previous v3.4.1 revision. This appears to be a minor update to the revision metadata rather than a change to study data.SummaryDifference0.1%

- Check96 days agoChange DetectedA new revision entry added: v3.4.1 to the history. The prior Notice about government funding and the earlier revision v3.4.0 are shown as deletions in the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.